Recently added
This page was added on 04 June 2021.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Sanofi-Aventis Australia
Administration route
Intramuscular injection
Subcutaneous injection
Vaccine group
Monovalent vaccines
Description:
Registered for use in infants and children aged 2 months to 5 years.
Monovalent Haemophilus influenzae type b (Hib) vaccine
Lyophilised powder in a monodose vial with a pre-filled diluent syringe.
Each 0.5 mL reconstituted dose contains:
- 10 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 18–30 µg tetanus protein (PRP-T)
Also contains traces of:
- trometamol
- latex
Contains traces of latex.
For Product Information and Consumer Medicine Information about Act-HIB visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed